Viemed Healthcare, Inc. (VMD): Price and Financial Metrics


Viemed Healthcare, Inc. (VMD): $9.70

-0.07 (-0.72%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

VMD POWR Grades


  • VMD scores best on the Quality dimension, with a Quality rank ahead of 96.01% of US stocks.
  • VMD's strongest trending metric is Quality; it's been moving down over the last 92 days.
  • VMD ranks lowest in Sentiment; there it ranks in the 24th percentile.

VMD Stock Summary

  • VMD's went public 1.74 years ago, making it older than only 2.28% of listed US stocks we're tracking.
  • With a year-over-year growth in debt of -48.61%, Viemed Healthcare Inc's debt growth rate surpasses just 7.52% of about US stocks.
  • Revenue growth over the past 12 months for Viemed Healthcare Inc comes in at 62.55%, a number that bests 91.94% of the US stocks we're tracking.
  • Stocks that are quantitatively similar to VMD, based on their financial statements, market capitalization, and price volatility, are ATEN, LRN, NTGR, AUDC, and VIOT.
  • Visit VMD's SEC page to see the company's official filings. To visit the company's web site, go to www.viemed.com.

VMD Stock Price Chart Interactive Chart >

Price chart for VMD

VMD Price/Volume Stats

Current price $9.70 52-week high $11.98
Prev. close $9.77 52-week low $6.43
Day low $9.66 Volume 173,300
Day high $9.85 Avg. volume 214,821
50-day MA $9.78 Dividend yield N/A
200-day MA $9.44 Market Cap 380.09M

Viemed Healthcare, Inc. (VMD) Company Bio


Viemed Healthcare, Inc. provides health care services. The Company offers respiratory disease management, neuromuscular care, home sleep testing, equipment solutions, sleep apnea treatment, and oxygen therapy services. Viemed Healthcare also offers rental of ventilator and peripheral equipment. Viemed Healthcare serves patients in the United States.

VMD Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$9.70$17.9 78%

Below please find a table outlining a discounted cash flow forecast for VMD, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Viemed Healthcare Inc ranked in the 68th percentile in terms of potential gain offered. More precisely, our analysis suggests the stock is undervalued by approximately 78.67% on a DCF basis. As for the metrics that stood out in our discounted cash flow analysis of Viemed Healthcare Inc, consider:

  • As a business, VMD is generating more cash flow than only 23.55% of positive cash flow stocks in the Healthcare.
  • VMD's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 48.51% of tickers in our DCF set.
  • Viemed Healthcare Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than only 0% of US stocks with positive free cash flow.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%74%
1%76%
2%78%
3%80%
4%81%
5%83%

RSCF, HOLX, CAH, CERT, and MOH can be thought of as valuation peers to VMD, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.


VMD Latest News Stream


Event/Time News Detail
Loading, please wait...

VMD Latest Social Stream


Loading social stream, please wait...

View Full VMD Social Stream

Latest VMD News From Around the Web

Below are the latest news stories about Viemed Healthcare Inc that investors may wish to consider to help them evaluate VMD as an investment opportunity.

Viemed Healthcare Announces First Quarter 2021 Financial Results

LAFAYETTE, La., May 03, 2021 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (TSX: VMD.TO and NASDAQ:VMD), a home medical equipment supplier that provides post-acute respiratory care services in the United States, announced today that it has reported its financial results for the three months ended March 31, 2021. Operational highlights (all dollar amounts are USD): Net revenues attributable to the Company's core business for the quarter ended March 31, 2021 were $25.5 million, an increase of $2.7 million or 12% over net core revenues reported for the comparable quarter ended March 31, 2020. Total net revenues for the current quarter were $28.4 million which included approximately $2.9 million for contact tracing services and product sales related to the COVID-19...

Yahoo | May 3, 2021

Viemed Healthcare Announces Date and Time for Conference Call

LAFAYETTE, La., April 20, 2021 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (TSX:VMD.TO and NASDAQ:VMD), a home medical equipment supplier that provides post-acute respiratory care services in the United States, announced today that it will host its Quarterly Conference Call on Tuesday, May 4, 2021 at 11:00 a.m. EST. Conference Call Details The details of the call are: Tuesday, May 4, 2021 at 11:00 a.m. EST US Toll Free Dial In: 1-877-407-0784 International Toll Free Dial In: 1-201-689-8560 Meeting ID Number: 13719010 Live Event Call me™ Link: https://callme.viavid.com/?callme=true&passcode=13707099&h=true&info=company-email&r=true&B=6 Participants can use the Participant dial-in #s above and be answered by an operator OR click the Call me™ link for instant te...

Yahoo | April 20, 2021

Viemed Healthcare, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 3, 2021 / Viemed Healthcare, Inc. (NASDAQ:VMD) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 3, 2021 at 11:00 AM Eastern Time.

Yahoo | March 3, 2021

Viemed Healthcare Announces Record 2020 Financial Results

LAFAYETTE, La., March 03, 2021 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (TSX: VMD.TO and NASDAQ:VMD), a home medical equipment supplier that provides post-acute respiratory care services in the United States, announced today that it has reported its financial results for the three months and year ended December 31, 2020. Operational highlights (all dollar amounts are USD): Net revenues attributable to the Company's core business for the quarter ended December 31, 2020 were $26.1 million, an increase of 22% over net revenues reported for the quarter ended December 31, 2019. Net revenues attributable to the Company's core business for the quarter ended December 31, 2020 were up approximately 5% over the quarter ended September 30, 2020. Total revenues for th...

Yahoo | March 3, 2021

Commonwealth Primary Care ACO and VieMed Healthcare announce an innovative chronic respiratory care and sleep management alliance

VieMed’s clinically proven care model being deployed in Arizona to improve outcomes in patients with impaired respiratory functionLAFAYETTE, La., Feb. 11, 2021 (GLOBE NEWSWIRE) -- VieMed Healthcare, Inc. (the “Company” or “VieMed”) (TSX: VMD.TO and NASDAQ:VMD), a home medical equipment supplier that provides post-acute respiratory care services in the United States, announced an innovative alliance with Commonwealth Primary Care ACO, LLC (“Commonwealth”) to bring VieMed’s best-in-class home respiratory equipment, services and technologies to Commonwealth’s independent physicians and the patients they serve. VieMed has a primary focus on Non-Invasive Ventilation at home (NIVH) and recently announced a completed NIVH study led by Dr. William Frazier, VieMed’s Chief Medical Officer. The st...

Yahoo | February 11, 2021

Read More 'VMD' Stories Here

VMD Price Returns

1-mo -6.19%
3-mo -3.96%
6-mo 5.90%
1-year 43.07%
3-year 198.46%
5-year N/A
YTD 25.00%
2020 25.16%
2019 63.16%
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7441 seconds.